BIO 181 Lecture Notes - Revascularization, Transcytosis, Carotid Artery Stenosis
Document Summary
Atheroma, epidemiology and physiopathology, the polyatheromatous patient: epidemiology 3. For the future 3: mechanisms of atherosclerosis 3. Aneurysm development 5: therapeutic impact points 5, preferential locations of atherosclerotic lesions 6, natural evolution of atheromatous disease 7. Atheroma risk factors (arf) 7: the polyatheromatous patient 7. Accepted therapies for all polyvascular patients 8. Intensive management of all modifiable risk factors 8. Medications with proven efficacy in reducing morbidity and mortality 8. Specific management of certain asymptomatic locations 9. Therapeutic education understanding of the disease 9. Annual clinical assessment of atheromatous lesions 10. Epidemiological studies mainly identify the complications caused by the disease. First cause of mortality in the world. Geographic variation: cardiovascular mortality rate higher in northern and eastern. European countries, intermediate in north america, lower in southern europe, china, and japan. These variations are related to the diversity of environmental factors and dietary habits rather than to genetic differences.
